- Home
- DYAI vs RAND Comparison
DYAI vs RAND Comparison
Compare DYAI & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DYAI | RAND |
|---|---|---|
| Founded | 1979 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.8M | 32.4M |
| IPO Year | 2003 | 1996 |
Fundamental Metrics
Financial Performance| Metric | DYAI | RAND |
|---|---|---|
| Price | $0.80 | $12.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 66.4K | 3.7K |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | ★ 9.67% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,495,389.00 | N/A |
| Revenue This Year | $12.52 | N/A |
| Revenue Next Year | $92.04 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 20.58 | N/A |
| 52 Week Low | $0.71 | $10.05 |
| 52 Week High | $1.55 | $24.99 |
Technical Indicators
Market Signals| Indicator | DYAI | RAND |
|---|---|---|
| Relative Strength Index (RSI) | 44.50 | 59.71 |
| Support Level | $0.73 | $10.31 |
| Resistance Level | $0.87 | $12.50 |
| Average True Range (ATR) | 0.06 | 0.48 |
| MACD | 0.00 | 0.11 |
| Stochastic Oscillator | 33.77 | 100.00 |
Price Performance
Historical ComparisonAbout DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.